Neomorph Revenue and Competitors

Location

$109M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Neomorph's estimated annual revenue is currently $5.4M per year.(i)
  • Neomorph's estimated revenue per employee is $77,500
  • Neomorph's total funding is $109M.

Employee Data

  • Neomorph has 70 Employees.(i)
  • Neomorph grew their employee count by 27% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.6M415%N/AN/A
#2
$188.5M520-1%N/AN/A
Add Company

Neomorph is a venture backed biotechnology company based in San Diego, California. The team at Neomorph is building a leading protein degradation company, focusing on ‘molecular glue' degraders. Our mission at Neomorph is to use this technology to solve critical problems in human health by the discovery and development of innovative new medicines against ‘undruggable targets'. The Neomorph team is composed of leaders from the academic and industrial worlds who have demonstrated years of commitment and success in the field, and who remain dedicated to advancing the technology and delivering highly impactful drugs. The Neomorph team is advancing the science and technology of molecular glue drug discovery, while prosecuting a pipeline of projects through clinical development. Neomorph has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute.

keywords:N/A

$109M

Total Funding

70

Number of Employees

$5.4M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Neomorph's People

NameTitleEmail/Phone
1
Principal ScientistReveal Email/Phone
2
Senior Associate ScientistReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Scientist IIReveal Email/Phone
5
Associate Principal ScientistReveal Email/Phone
6
Senior ScientistReveal Email/Phone
7
Senior ScientistReveal Email/Phone
8
VP, Business DevelopmentReveal Email/Phone
9
Scientist I, BiologyReveal Email/Phone
10
VP ChemistryReveal Email/Phone

Neomorph News

2022-03-30 - David 8's Perfect Alien Franchise Death (& Will It Ever Happen?)

Throughout both Alien prequels, Xenomorph prototypes such as the Deacon or Neomorph were seen, leading to Alien: Covenant's Protomorph.

2022-03-22 - Neomorph, Inc. to Participate in Upcoming Guggenheim ...

Neomorph, Inc. to Participate in Upcoming Guggenheim Healthcare Talks – Targeted Protein Degradation Day. March 10, 2022 08:00 AM Eastern...

2020-12-23 - Neomorph Raises $109M in Series A Financing

Neomorph, Inc., a San Diego, CA-based biotechnology company, raised $109m in Series A financing. The company intends to use the funds to further develop its platform, advance lead programs, and expand the research team. Deerfield Management Company established Neomorph earlier this year with s ...

2020-12-22 - Neomorph Finds $109M

San Diego-based Neomorph, a biotech startup focused on protein degradation, said today that it has raised $109M in a Series A funding. The funding came from Deerfield Management. The company said its targeted protein degradation technology is aimed at developing novel therapeutics across a broad ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17M709%N/A
#2
$6.4M7021%N/A
#3
$11.3M7011%N/A
#4
$17M701%N/A
#5
$9.5M70-3%N/A